ARCHIVES

Dendreon’s Provenge Approved For Prostate Cancer Treatment

This article is from The Cancer Letter archive.

Vol. 36 No. 16 | April 30, 2010

Download PDF Visit The Full Archive

Related Articles

J&J, Amgen Settle Lawsuit Over ESAs As FDA Prepares Another Label Change.

July 18, 2008

In Brief: Bruce Chamber Is DeVita’s Choice as Permanent Director Of DCT; Six New RCDAs Funded In FY 1982

June 11, 1982

ODAC Okays Photofrin for Obstructive Esophageal Cancer

September 23, 1994

NCI Workshop Not “A Formality,” Baines Responds To Kopans

November 19, 1993

Panel May Take On OMB In Battle to Restore NCI Construction Funds; Two Will Be Funded In FY ‘83

November 12, 1982

Funding opportunities listed.

January 9, 2004